0001921094-23-000551.txt : 20230821
0001921094-23-000551.hdr.sgml : 20230821
20230821144153
ACCESSION NUMBER: 0001921094-23-000551
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230821
DATE AS OF CHANGE: 20230821
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Denali Therapeutics Inc.
CENTRAL INDEX KEY: 0001714899
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 463872213
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-38311
FILM NUMBER: 231188859
BUSINESS ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 866-8548
MAIL ADDRESS:
STREET 1: 161 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Watts Ryan J.
CENTRAL INDEX KEY: 0001724310
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: C/O DENALI THERAPEUTICS INC.
STREET 2: 151 OYSTER POINT BLVD., 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
144
1
primary_doc.xml
144
0001724310
XXXXXXXX
LIVE
0001714899
Denali Therapeutics Inc.
001-38311
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
(650) 866-8548
Watts Ryan J.
Officer
Director
Common
Charles Schwab & Co., Inc.
3000 Schwab Way
Westlake
TX
76262
2309
52167.00
137422131
08/21/2023
NASDAQ
Common
08/18/2023
Restricted Stock Lapse - See Remarks
Denali Therapeutics Inc.
N
2309
08/18/2023
Equity Compensation
N
RYAN J WATTS
161 Oyster Point Blvd
South San Francisco
CA
94080
Denali Therapeutics Inc.
06/16/2023
50000
1570050.00
RYAN J WATTS
161 Oyster Point Blvd
South San Francisco
CA
94080
Denali Therapeutics Inc.
08/10/2023
2526
63223.00
Shares sold to cover tax obligation from settlement of vested Restricted Stock Units.
08/21/2023
RYAN J WATTS